Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP615955.RASkcSmcX_uMCkEK1EBK_XgpczYNOUkG2YmSKlrguHYW4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP615955.RASkcSmcX_uMCkEK1EBK_XgpczYNOUkG2YmSKlrguHYW4130_assertion type Assertion NP615955.RASkcSmcX_uMCkEK1EBK_XgpczYNOUkG2YmSKlrguHYW4130_head.
- NP615955.RASkcSmcX_uMCkEK1EBK_XgpczYNOUkG2YmSKlrguHYW4130_assertion description "[The median percentage of MNDA-dim myeloid precursors in MDS cases was 67.4% (range, 0.7%-97.5%; interquartile range, 44.9%-82.7%) of myeloid cells, with bimodal MNDA expression in most MDS samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615955.RASkcSmcX_uMCkEK1EBK_XgpczYNOUkG2YmSKlrguHYW4130_provenance.
- NP615955.RASkcSmcX_uMCkEK1EBK_XgpczYNOUkG2YmSKlrguHYW4130_assertion evidence source_evidence_literature NP615955.RASkcSmcX_uMCkEK1EBK_XgpczYNOUkG2YmSKlrguHYW4130_provenance.
- NP615955.RASkcSmcX_uMCkEK1EBK_XgpczYNOUkG2YmSKlrguHYW4130_assertion SIO_000772 21350091 NP615955.RASkcSmcX_uMCkEK1EBK_XgpczYNOUkG2YmSKlrguHYW4130_provenance.
- NP615955.RASkcSmcX_uMCkEK1EBK_XgpczYNOUkG2YmSKlrguHYW4130_assertion wasDerivedFrom befree-20140225 NP615955.RASkcSmcX_uMCkEK1EBK_XgpczYNOUkG2YmSKlrguHYW4130_provenance.
- NP615955.RASkcSmcX_uMCkEK1EBK_XgpczYNOUkG2YmSKlrguHYW4130_assertion wasGeneratedBy ECO_0000203 NP615955.RASkcSmcX_uMCkEK1EBK_XgpczYNOUkG2YmSKlrguHYW4130_provenance.